News – Archive

Grindeks has successfully completed the Phase 1 Clinical Study of Its New Investigational Medicinal Product Methyl-GBB

JSC Grindeks announces that it has completed the Phase 1 clinical study of its new investigational medicinal product metyl-GBB. This new investigational medicinal product is...

05/03/2020

Profit of Grindeks reaches 12.9 million euro in 2019

Today, on 28 February, the JSC Grindeks submitted the non-audited consolidated financial statements of 2019 to Nasdaq Riga. Non-audited financial results indicate that the Group’s...

28/02/2020

Regarding changes in the Management Board of Grindeks subsidiary Kalceks

As of February 18, the Management Board of JSC Kalceks, a subsidiary of JSC Grindeks, has been changed – the member of the Management Board...

19/02/2020

Juris Hmelnickis appointed as the Chairman of the Board of Grindeks

JSC Grindeks announces that the company’s Supervisory Council has approved Juris Hmelnickis as the Chairman of the Board. Kirovs Lipmans, Chairman of the Council of...

04/02/2020

The Ambassador of Benin to Latvia visits Grindeks

On Friday, January 17, Ambassador Extraordinary and Plenipotentiary of the Republic of Benin to Latvia, Eusebe Agbangla and Honorary Consul of the Republic of Benin,...

17/01/2020

JSC Grindeks receives a certificate of Saudi Food and Drug Authority

JSC Grindeks informs that the company has received a certification of Saudi Food and Drug Authority certifying the compliance of Grindeks final dosage forms –tablets...

19/12/2019

The Ambassador of Japan to Latvia visits Grindeks

On Tuesday, December 3, Ambassador Extraordinary and Plenipotentiary of Japan to Latvia Yasuhiro Kawaguchi and Attaché of Japanese Embassy in Latvia Kentaro Morimoto visited JSC...

03/12/2019

Grindeks profit in the first nine months of 2019 increases by 17% and reaches 8.9 million euro

Today, on November 28, JSC Grindeks submitted the non-audited consolidated financial statements of the first nine months of 2019 to Nasdaq Riga. Non-audited financial results...

29/11/2019

Grindeks product Viprosal B® receives „Russian Pharma Awards”® recognition

On November 14 in Russia’s capital city Moscow the eighth pharmaceutical industry product competition “Russian Pharma Awards”® ceremony was held during which Grindeks product Viprosal...

21/11/2019